Amplexor's Monika Vytiskova, senior Life Sciences industry expert, was featured in a recent issue of PharmaTimes, the UK's leading pharmaceutical magazine.
As life sciences companies’ international ambitions grow, and global regulatory scrutiny in parallel, managing translated content is becoming ever more complex. So the promise of neural machine learning as a potential solution is appealing. But just how far can the technology go in reducing workloads and improving accuracy and turnaround times?
In Making Sense Of It, Monika shares insights on how to navigate through the evolving challenges with advanced technologies such as neural machine translation and AI.